| Patents for C07C 59 - Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (14,643) |
|---|
| 10/18/2006 | CN1847212A Process for manufacturing high purity methacrylic acid |
| 10/18/2006 | CN1280333C Crystalline polyglycolic acid, polyglycolic acid composition and production process thereof |
| 10/18/2006 | CN1280271C Arylphenyl-substituted cyclic keto-enols |
| 10/18/2006 | CN1279893C Surfactant compounds and uses thereof |
| 10/17/2006 | US7122686 Analogs of discodermolide and dictyostatin-1, intermediates therefor and methods of synthesis thereof |
| 10/17/2006 | US7122663 Oxidation of alcohols to aldehydes, ketones, acids |
| 10/12/2006 | WO2006046854A3 Flavour modulating substances |
| 10/12/2006 | WO2005117854A3 Aryl ketone compounds and compositions for delivering active agents |
| 10/12/2006 | US20060229281 Cycloalkyl-Hydroxyl Compounds and Compositions for Cholesterol Management and Related Uses |
| 10/11/2006 | EP1708987A1 L-(-)-moprolol l-(+)-tartrate |
| 10/11/2006 | CN1279014C Vitamin A analogue derivative with antiangiogenic, antitumoral and proapoptotic activities |
| 10/11/2006 | CN1279013C Process for preparing carboxylic acids and derivatives thereof |
| 10/10/2006 | USRE39333 permitting a lithium amide to act upon a mixture of an acetic acid ester and a 3-hydroxypropionic acid derivative; use of inexpensive starting materials |
| 10/10/2006 | US7119221 treating and preventing a variety of diseases and conditions such as aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic retinopathy, dyslipidemia, dyslipoproteinemia, hypertension, impotence, insulin resistance, peroxisome proliferator activated receptor associated disorders |
| 10/10/2006 | US7119198 beta-aryl-alpha-oxysubstituted alkylcarboxylic acids, usch as Ethyl (E/Z)-3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropenoate, used as antilipemic or hypoglycemic agents |
| 10/05/2006 | WO2006104610A2 Trans carotenoids, their synthesis, formulation and uses |
| 10/05/2006 | US20060223888 Valproic acid analogues and pharmaceutical composition thereof |
| 10/05/2006 | US20060223842 such as (5-acetyl-1-methyl-1H-pyrrol-2-yl)acetyl methanesulphonamide, used for the of treatment of psoriasis, ulcerative colitis, melanoma, chronic obstructive pulmonary disease (COPD), skin disorders, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis and reperfusion injuries after ischemia |
| 10/05/2006 | CA2598882A1 Trans carotenoids, their synthesis, formulation and uses |
| 10/04/2006 | EP1707211A1 Ceramidase inhibitor |
| 10/04/2006 | CN1277804C Process for producing a fluorine-containing compound by liquid phase fluorination |
| 10/04/2006 | CN1277794C Preparation of levulinate from glucose by molecular screen catalytic hydrolysis |
| 10/04/2006 | CN1277787C Optical dividing method for sclare lactone precursor |
| 10/03/2006 | US7115784 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 10/03/2006 | US7115643 simplified manner using considerably less process steps and with considerably improved yield and diastereoselectivity |
| 10/03/2006 | CA2319801C Improved separation processes |
| 09/27/2006 | EP1705169A2 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 09/27/2006 | EP1704856A1 Hsp90 family protein inhibitor |
| 09/27/2006 | EP1635809A4 Resolution of alpha-(phenoxy)phenylacetic acid derivatives |
| 09/27/2006 | CN1276909C Synthesis method for ether carboxylate as oil displacement system |
| 09/27/2006 | CN1276907C Splitting method of (R)-(-)-2-hydroxy-2-(2-chlorphenyl)acetic acid |
| 09/26/2006 | US7112597 5-(Substituted thiazolylethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
| 09/21/2006 | WO2006097314A1 Method for producing optically active 3-phenylpropionic acid derivatives and follow-on products of the latter |
| 09/21/2006 | US20060211768 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor |
| 09/21/2006 | US20060211765 Novel compounds |
| 09/21/2006 | DE102005012408A1 Preparation of optically active 3-phenylpropionic acid derivative, useful to prepare halo-phenyl compound, comprises hydrogenating cis-isomer mixture of phenyl compound; crystallizing the enantiomer mixture and isolating the solid material |
| 09/21/2006 | CA2601503A1 Phenol derivatives and their use to modulate pkb activity |
| 09/20/2006 | EP1702910A1 Octahydronaphthalene derivative and medicine |
| 09/20/2006 | EP1701938A1 1,3-diphenylprop-2-en-1-one derivative compounds, preparation method thereof and uses of same |
| 09/20/2006 | CN1835905A Rare earth metal compound in aqueous solvent, method for producing same, and method for producing ceramic powder using same |
| 09/20/2006 | CN1834087A Organo-iodine complex |
| 09/20/2006 | CN1275938C Thyroid hormone receptor atagonists for treating cardiac and metabolic disorders II |
| 09/20/2006 | CN1275916C Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 09/19/2006 | US7109242 Carboxylic compound and medicine comprising the same |
| 09/14/2006 | WO2006067450A3 Modulator |
| 09/14/2006 | US20060205723 5-(Substituted oxazolyl- or thiazolyl-ethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
| 09/14/2006 | US20060201879 Contacting an aqueous levulinic acid phase with a liquid water-immiscible alcohol phase in the presence of an esterification catalyst, the phases being separated from each other by a membrane that is permeable to levulinic acid but not to water |
| 09/13/2006 | EP1699775A2 Compounds having selective cytochrome p450rai-1 or selective cytochrome p450rai-2 inhibitory activity and methods of obtaining the same |
| 09/13/2006 | EP1699771A1 A process for the liquefaction of lignocellulosic material |
| 09/13/2006 | EP1286944B1 A solvent exchange process |
| 09/13/2006 | CN1832916A Process for separating and recovering 3-hydroxypropionic acid and acrylic acid |
| 09/13/2006 | CN1832915A Process for separating and recovering 3-hydroxypropionic acid and acrylic acid |
| 09/13/2006 | CN1830941A Compound having hydroxycarbonyl-halogenoalkyl side chain |
| 09/12/2006 | US7105541 Naphthyl compounds, intermediates, compositions, and methods of use |
| 09/12/2006 | US7105471 Arylphenyl-substituted cyclic ketoenols |
| 09/08/2006 | WO2006092208A1 Biologically degradable gas hydrate inhibitors |
| 09/06/2006 | EP1697339A1 3-(4-benzyloxyphenyl)propanoic acid derivatives |
| 09/06/2006 | CN1827686A Crystalline polyglycolic acid, polyglycolic acid composition and production process thereof |
| 09/06/2006 | CN1273436C Method for recovering 2-keto-L-gluconic acid from gluconic acid crystallization mother liquor |
| 09/05/2006 | US7101915 P-terphenyl compounds |
| 09/05/2006 | US7101910 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 09/05/2006 | US7101831 Compositions of material, especially lubricants and pressure transmitting means, the production and use thereof |
| 08/31/2006 | WO2006090072A1 Ppar activator derivatives, preparation method thereof and use of same in therapeutics |
| 08/31/2006 | WO2004103074A8 Copper salts of organic acids and use thereof as fungicides |
| 08/31/2006 | US20060194973 Trans carotenoids, their synthesis, formulation and uses |
| 08/31/2006 | US20060194877 Creatine hydroxycitric acids salts and methods for their production and use in individuals |
| 08/31/2006 | US20060194876 Substantially pure tolterodine tartrate and process for preparing thereof |
| 08/31/2006 | US20060194786 Process and intermediates for preparing benzazepines |
| 08/31/2006 | US20060194744 Illudin analogs useful as antitumor agents |
| 08/30/2006 | EP1695955A1 Compounds having lysophosphatidic acid receptor antagonism and uses thereof |
| 08/30/2006 | EP1385815B1 Process for the removal of undesired flavour and odour components from potassium lactate |
| 08/23/2006 | EP1692127A2 Triphenylethylene compounds as selective estrogen receptor modulators |
| 08/23/2006 | EP1692089A2 A process for resolving, optionally substituted, mandelic acids by salt formation with a chiral base cyclic amide |
| 08/23/2006 | CN1820828A Frequently pole-reversing electroosmosis method for extracting and concentrating sodium lactate from garbage fermentation liquid |
| 08/22/2006 | US7094926 Process for producing optically active carboxylic acid substituted in 2-position |
| 08/17/2006 | US20060183929 Crystals of the sodium salt of pravastatin |
| 08/16/2006 | EP1690882A1 Aqueous compositions containing perfluoropolyether di-carboxylic salts for the oleo-repellent paper treatment |
| 08/16/2006 | EP1542957A4 Process for preparing fluorocarboxylic acids |
| 08/16/2006 | CN1820076A Method for producing organic acid |
| 08/16/2006 | CN1819986A Preparation of 1,3-diphenylprop-2-en-1-one derivatives |
| 08/16/2006 | CN1269788C Bicyclic aromatic compound and its application in human medicines or animal medicines and cosmetics teconology |
| 08/15/2006 | US7091246 dual mineral salt; thermal stability, simplified process |
| 08/15/2006 | US7091230 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 08/15/2006 | CA2194859C Enzymatic production of gluconic acid or its salts |
| 08/10/2006 | US20060178468 suitable to improve the dispersibility of coloring materials or solids in an ink or toner; alkenyl ether compound that comprises at least one of an aromatic carboxylic acid having a fluorine atom and an aromatic carboxylic acid ester having a fluorine atom, which is a polymeric compound |
| 08/10/2006 | US20060178434 Butenoic acid derivatives processes for the preparation thereof pharmaceutical compositions comprising them and use for the treatment of dyslipidaemia atherosclerosis and diabetes |
| 08/10/2006 | DE102005004228A1 Solubilisat einer wasserlöslichen organischen Säure sowie ein Verfahren zu seiner Herstellung Solubilizate of a water soluble organic acid and a process for its preparation |
| 08/09/2006 | EP1688138A1 Receptor function regulating agent |
| 08/09/2006 | EP1687250A1 Process for producing optically active 3-(4-hydroxyphenyl)propionic acids |
| 08/09/2006 | EP1385593B1 Process for obtaining an organic acid from an organic acid ammonium salt, an organic acid amide, or an alkylamine organic acid complex |
| 08/09/2006 | EP0970952B1 Processes for preparing 2-omega-alkoxycarbonylalkanoyl)-4-butanolides, omega-hydroxy-omega-3)-keto fatty esters, and derivatives thereof |
| 08/09/2006 | CN1816516A Method for selective carbohydrate oxidation using supported gold catalysts |
| 08/08/2006 | US7087790 Benzotropolone derivatives and modulation of inflammatory response |
| 08/08/2006 | US7087599 Estrogen receptor modulators |
| 08/03/2006 | US20060173042 Process for the preparation of fexofenadine |
| 08/02/2006 | EP1685120A1 Colouring hydrosoluble yellow preparation derived from dihydrochalcones |
| 08/02/2006 | EP1173400B1 Process for the preparation of 3,4-dihydroxybutanoic acid and derivatives thereof from substituted pentose sugars |
| 08/01/2006 | US7084177 Antidiabetic agents |
| 08/01/2006 | US7083705 reacting an alcohol with an ether to form an ester, then with fluorine gas to form a perfluoro composition; precursor for a fluorine resin material. |
| 08/01/2006 | CA2135479C Styryl derivatives, their preparation and use as pde-iv inhibitors |